Vitiligo, New Treatment and Serum s100B

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 2, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Vitiligo, Generalized
Interventions
DRUG

Baricitinib

oral baricitinib 4mg for adults and 2mg for children 10-16 years for group A

DRUG

oral mini pulse

pulse dose of oral dexamethasone 2.5mg for adults for two consecutive days per week and half the dose for children

RADIATION

Narrow Band UVB Treatment

narrowband ultraviolet rays B phototherapy two sessions per week

Trial Locations (1)

Unknown

RECRUITING

Qena university hospital, Qena faculty of medicine, Qina

All Listed Sponsors
lead

South Valley University

OTHER